MARKET TALK: ABN AMRO Keeps IBA Health At Buy 31/08/06 09:56:00+
0956 [Dow Jones] STOCK CALL: ABN AMRO says IBA Health's (IBA.AU) normalized FY net profit of A$19.3 million beats its forecast of A$16.9 million. Reported net profit of A$15.6 million included A$3.2 million one-off restructuring cost. "Importantly, FY07 guidance has been reconfirmed. Given the strong start to FY07, we think this may prove conservative," broker says, adding growth in Asia region is key. Maintains Buy rating. Target price A$1.26 vs last trade 87 cents. (SVM)
IBA Price at posting:
0.0¢ Sentiment: Buy Disclosure: Not Held